On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected to inconsistent use of measures to control mosquito populations, according to findings published in the New England Journal of Medicine.

The trend is worrisome, the NIAID-funded scientists state, because resistance mutations they tracked are taking root and spreading. Researchers at the University of California at San Francisco (UCSF), funded in part by NIAID’s International Centers of Excellence for Malaria Research program, led the international collaboration.